Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma.
Xifeng Wu(Zhejiang Lab), Lu‐Yu Hwang(The University of Texas Health Science Center at Houston), Mohsin Hassan(University of Bern), M R Spitz(The University of Texas MD Anderson Cancer Center), Yehuda Z. Patt(Anderson Hospital), R. Palmer Beasley(National Taiwan University), Jun Gu(Peking University)
PubMed
July 1, 1998
Cited by 60
Related Papers
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
|The Lancet|1981|2.9k
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes
|Nature Genetics|2017|804
Plasma Levels of Insulin-Like Growth Factor-I and Lung Cancer Risk: a Case-Control Analysis
|JNCI Journal of the National Cancer Institute|1999|558
Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study
|The Lancet Oncology|2016|405
Risk Factors for Perinatal Transmission of Hepatitis C Virus (HCV) and the Natural History of HCV Infection Acquired in Infancy
|The Journal of Infectious Diseases|2005|398